The PE Ratio as of December 2025 (TTM) for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) is 16.31

According to Shenzhen Hepalink Pharmaceutical Group Co., Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is 16.31. This represents a change of 40.60% compared to the average of 11.60 of the last 4 quarters.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) Historical PE Ratio (quarterly & annually)

How has 9989.HK PE Ratio performed in the past?

The mean historical PE Ratio of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. over the last ten years is 42.58. The current 16.31 PE Ratio has changed 3.73% with respect to the historical average. Over the past ten years (40 quarters), 9989.HK's PE Ratio was at its highest in in the June 2017 quarter at 387.22. The PE Ratio was at its lowest in in the March 2017 quarter at -537.37.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) PE Ratio by Quarter and Year

Discovering the peaks and valleys of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) Average PE Ratio

How has 9989.HK PE Ratio performed in the past?

The current PE Ratio of Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) PE Ratio vs. Peers

How is 9989.HK’s PE Ratio compared to its peers?

Shenzhen Hepalink Pharmaceutical Group Co., Ltd.’s PE Ratio is greater than Ab&B Bio Tech Co Ltd. (-67.76), greater than HUTCHMED (China) Limited (4.98), greater than Consun Pharmaceutical Group Limited (12.43), greater than CanSino Biologics Inc. (-112.13), less than Shanghai Conant Optical Co., Ltd. (46.59), greater than Sihuan Pharmaceutical Holdings Group Ltd. (-131.59), greater than China Traditional Chinese Medicine Holdings Co. Limited (-37.12), greater than Everest Medicines Limited (-21.06), less than Shandong Xinhua Pharmaceutical Company Limited (28.59), greater than SSY Group Limited (13.11),

Build a custom stock screener for Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Shenzhen Hepalink Pharmaceutical Group Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (9989.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Shenzhen Hepalink Pharmaceutical Group Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.